Dovato 50-300 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQR4D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,421
Award facts
- Contract value 100% obligated
- $72,420.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Dovato 50-300 mg tablets (30-count units) with a contract value of $72,420.66. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver pharmaceuticals across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order aligns with DLA's ongoing efforts to secure pharmaceutical supplies through competitive awards and reflects AmerisourceBergen's established role as a primary supplier within the Defense Health Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQR4D?
SPE2DR26FQR4D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FQR4D worth?
The government has obligated $72,421 on SPE2DR26FQR4D.
Is contract SPE2DR26FQR4D an order under another contract?
Yes. SPE2DR26FQR4D is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQR4D competed?
The extent of competition for SPE2DR26FQR4D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award